202 related articles for article (PubMed ID: 17634219)
1. TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.
Murphy SL; Gaulton GN
J Virol; 2007 Oct; 81(19):10777-85. PubMed ID: 17634219
[TBL] [Abstract][Full Text] [Related]
2. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.
Chung M; Kizhatil K; Albritton LM; Gaulton GN
J Virol; 1999 Nov; 73(11):9377-85. PubMed ID: 10516046
[TBL] [Abstract][Full Text] [Related]
3. Neuropathogenic murine leukemia virus TR1.3 induces selective syncytia formation of brain capillary endothelium.
Landers MC; Dugger N; Quadros M; Hoffman PM; Gaulton GN
Virology; 2004 Mar; 321(1):57-64. PubMed ID: 15033565
[TBL] [Abstract][Full Text] [Related]
4. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
5. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
6. Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR.
Murphy SL; Honczarenko MJ; Dugger NV; Hoffman PM; Gaulton GN
J Virol; 2004 Aug; 78(15):8392-9. PubMed ID: 15254211
[TBL] [Abstract][Full Text] [Related]
7. Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.
Murphy SL; Chung-Landers M; Honczarenko M; Gaulton GN
J Virol; 2006 May; 80(9):4601-9. PubMed ID: 16611920
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
Takeda A; Matano T
Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
[TBL] [Abstract][Full Text] [Related]
9. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
[TBL] [Abstract][Full Text] [Related]
10. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
11. Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells.
Kubo Y; Ishimoto A; Amanuma H
Arch Virol; 2003 Oct; 148(10):1899-914. PubMed ID: 14551814
[TBL] [Abstract][Full Text] [Related]
12. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
[TBL] [Abstract][Full Text] [Related]
13. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
Menéndez-Arias L; Gotte D; Oroszlan S
Virology; 1993 Oct; 196(2):557-63. PubMed ID: 8372434
[TBL] [Abstract][Full Text] [Related]
14. Avian reovirus-induced syncytium formation is independent of infectious progeny virus production and enhances the rate, but is not essential, for virus-induced cytopathology and virus egress.
Duncan R; Chen Z; Walsh S; Wu S
Virology; 1996 Oct; 224(2):453-64. PubMed ID: 8874506
[TBL] [Abstract][Full Text] [Related]
15. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
Lin G; Murphy SL; Gaulton GN; Hoxie JA
J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
[TBL] [Abstract][Full Text] [Related]
16. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
[TBL] [Abstract][Full Text] [Related]
17. Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation.
Wallin M; Ekström M; Garoff H
J Virol; 2006 Oct; 80(19):9921-5. PubMed ID: 16973599
[TBL] [Abstract][Full Text] [Related]
18. An anti-HIV peptide construct derived from the cleavage region of the Env precursor acts on Env fusogenicity through the presence of a functional cleavage sequence.
Barbouche R; Sabatier JM; Fenouillet E
Virology; 1998 Aug; 247(2):137-43. PubMed ID: 9705906
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.
Li M; Yang C; Compans RW
J Virol; 2001 Mar; 75(5):2337-44. PubMed ID: 11160737
[TBL] [Abstract][Full Text] [Related]
20. Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus.
Park BH; Lavi E; Blank KJ; Gaulton GN
J Virol; 1993 Oct; 67(10):6015-24. PubMed ID: 8396666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
